155 related articles for article (PubMed ID: 7026250)
41. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
[TBL] [Abstract][Full Text] [Related]
42. Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.
Ginks WR; Redwood DR
Br Heart J; 1980 Sep; 44(3):259-64. PubMed ID: 7426183
[TBL] [Abstract][Full Text] [Related]
43. Favorable effects of hydralazine on the hemodynamic response to isometric exercise in chronic severe aortic regurgitation.
Elkayam U; McKay CR; Weber L; Eisenberg D; Rahimtoola SH
Am J Cardiol; 1984 Jun; 53(11):1603-7. PubMed ID: 6731306
[TBL] [Abstract][Full Text] [Related]
44. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Greenberg BH; Massie BM
Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
[No Abstract] [Full Text] [Related]
45. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
[TBL] [Abstract][Full Text] [Related]
46. Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure.
Mettauer B; Rouleau JL; Burgess JH
Am Heart J; 1985 Apr; 109(4):840-7. PubMed ID: 3984838
[TBL] [Abstract][Full Text] [Related]
47. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
Daly P; Rouleau JL; Cousineau D; Burgess JH; Chatterjee K
Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637
[TBL] [Abstract][Full Text] [Related]
48. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
[TBL] [Abstract][Full Text] [Related]
49. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
50. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
Moskowitz RM; Cohn JN
Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
[TBL] [Abstract][Full Text] [Related]
51. Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure.
Ueda K; Sakai M; Matsushita S; Kuwajima I; Murakami M
Jpn Heart J; 1983 Sep; 24(5):711-21. PubMed ID: 6366290
[TBL] [Abstract][Full Text] [Related]
52. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
Mehta J; Pepine CJ; Conti CR
Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
[TBL] [Abstract][Full Text] [Related]
53. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
Sladen RN; Rosenthal MH
J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
[TBL] [Abstract][Full Text] [Related]
54. Oral hydralazine in patients with pulmonary vascular disease secondary to congenital heart disease.
Fripp RR; Gewitz MH; Werner JC; Whitman V; Rashkind WJ
Am J Cardiol; 1981 Aug; 48(2):380-2. PubMed ID: 7270444
[TBL] [Abstract][Full Text] [Related]
55. Effects of hydralazine on cardiopulmonary function in canine low-pressure pulmonary edema.
Ghignone M; Girling L; Prewitt RM
Anesthesiology; 1983 Sep; 59(3):187-90. PubMed ID: 6881582
[TBL] [Abstract][Full Text] [Related]
56. Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.
Mehta J; Pepine CJ; Conti CR
Br Heart J; 1978 Aug; 40(8):845-50. PubMed ID: 99155
[TBL] [Abstract][Full Text] [Related]
57. Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Rapaport E
Circulation; 1980 Feb; 61(2):316-23. PubMed ID: 7351056
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
[No Abstract] [Full Text] [Related]
59. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
N Engl J Med; 1982 Jan; 306(2):57-62. PubMed ID: 7053487
[TBL] [Abstract][Full Text] [Related]
60. Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
Ren JH; Unverferth DV; Magorien RD; Leier CV
Arch Intern Med; 1985 Apr; 145(4):641-4. PubMed ID: 3985726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
